Yeremchenko О. A. Alternative strategies for investing in corporate R&D (on the example of the global pharmaceutical industry). Economics of Science, [S. l.], v. 4, n. 4, p. 309–317, 2018. DOI: 10.22394/2410-132X-2018-4-4-309-317. Disponível em: https://ecna.owebs.ru/article/view/23113. Acesso em: 8 nov. 2026.